Chesley Taft & Associates LLC Eli Lilly & CO Transaction History

Chesley Taft & Associates LLC

  • $2.13 Billion
  • Q4 2024

A detailed history of Chesley Taft & Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 22,323 shares of LLY stock, worth $17.5 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
22,323
Previous 22,383 0.27%
Holding current value
$17.5 Million
Previous $19.8 Million 13.09%
% of portfolio
0.81%
Previous 0.95%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$727.2 - $932.06 $43,632 - $55,923
-60 Reduced 0.27%
22,323 $17.2 Million
Q3 2024

Oct 07, 2024
SELL
$772.14 - $960.02 $131,263 - $163,203
-170 Reduced 0.75%
22,383 $19.8 Million
Q2 2024

Jul 19, 2024
BUY
$724.87 - $909.04 $843,023 - $1.06 Million
1,163 Added 5.44%
22,553 $20.4 Million
Q1 2024

Apr 15, 2024
SELL
$592.2 - $792.28 $74,025 - $99,035
-125 Reduced 0.58%
21,390 $16.6 Million
Q4 2023

Jan 11, 2024
BUY
$525.19 - $619.13 $2.03 Million - $2.39 Million
3,864 Added 21.89%
21,515 $12.5 Million
Q3 2023

Oct 10, 2023
SELL
$434.7 - $599.3 $400,793 - $552,554
-922 Reduced 4.96%
17,651 $9.48 Million
Q2 2023

Jul 17, 2023
SELL
$350.74 - $468.98 $534,527 - $714,725
-1,524 Reduced 7.58%
18,573 $8.71 Million
Q1 2023

Apr 11, 2023
SELL
$310.63 - $364.82 $124,562 - $146,292
-401 Reduced 1.96%
20,097 $6.9 Million
Q4 2022

Jan 19, 2023
SELL
$321.55 - $374.67 $828,634 - $965,524
-2,577 Reduced 11.17%
20,498 $0
Q3 2022

Oct 13, 2022
BUY
$296.48 - $337.87 $38,542 - $43,923
130 Added 0.57%
23,075 $7.46 Million
Q2 2022

Jul 07, 2022
BUY
$278.73 - $327.27 $55,746 - $65,454
200 Added 0.88%
22,945 $7.44 Million
Q1 2022

Apr 14, 2022
BUY
$234.69 - $291.66 $2,346 - $2,916
10 Added 0.04%
22,745 $7.01 Million
Q4 2021

Jan 05, 2022
BUY
$224.85 - $279.04 $14,615 - $18,137
65 Added 0.29%
22,735 $6.28 Million
Q3 2021

Oct 05, 2021
BUY
$221.6 - $272.71 $91,964 - $113,174
415 Added 1.86%
22,670 $5.24 Million
Q2 2021

Jul 07, 2021
BUY
$180.55 - $233.54 $19,860 - $25,689
110 Added 0.5%
22,255 $5.11 Million
Q1 2021

Apr 06, 2021
BUY
$164.32 - $212.72 $41,080 - $53,180
250 Added 1.14%
22,145 $4.09 Million
Q4 2020

Jan 11, 2021
SELL
$130.46 - $172.63 $56,097 - $74,230
-430 Reduced 1.93%
21,895 $3.7 Million
Q3 2020

Oct 08, 2020
SELL
$146.22 - $169.13 $131,598 - $152,217
-900 Reduced 3.88%
22,325 $3.31 Million
Q2 2020

Jul 08, 2020
BUY
$136.42 - $164.18 $79,805 - $96,045
585 Added 2.58%
23,225 $3.81 Million
Q1 2020

Apr 15, 2020
BUY
$119.05 - $147.35 $175,598 - $217,341
1,475 Added 6.97%
22,640 $3.14 Million
Q4 2019

Jan 10, 2020
BUY
$106.92 - $132.43 $25,660 - $31,783
240 Added 1.15%
21,165 $2.78 Million
Q3 2019

Oct 07, 2019
SELL
$106.79 - $116.16 $59,802 - $65,049
-560 Reduced 2.61%
20,925 $2.34 Million
Q2 2019

Jul 10, 2019
BUY
$110.79 - $129.32 $13,848 - $16,165
125 Added 0.59%
21,485 $2.38 Million
Q1 2019

Apr 05, 2019
BUY
$111.31 - $131.02 $174,756 - $205,701
1,570 Added 7.93%
21,360 $2.77 Million
Q4 2018

Jan 07, 2019
BUY
$105.9 - $118.64 $1.68 Million - $1.88 Million
15,870 Added 404.85%
19,790 $2.29 Million
Q3 2018

Oct 12, 2018
SELL
$85.86 - $107.31 $30,051 - $37,558
-350 Reduced 8.2%
3,920 $421,000
Q2 2018

Jul 12, 2018
SELL
$75.7 - $86.88 $28,766 - $33,014
-380 Reduced 8.17%
4,270 $364,000
Q1 2018

Apr 11, 2018
SELL
$74.21 - $87.6 $28,125 - $33,200
-379 Reduced 7.54%
4,650 $360,000
Q4 2017

Jan 10, 2018
SELL
$81.94 - $87.89 $1,147 - $1,230
-14 Reduced 0.28%
5,029 $425,000
Q3 2017

Oct 13, 2017
BUY
$77.07 - $85.54 $388,664 - $431,378
5,043
5,043 $431,000

Others Institutions Holding LLY

# of Institutions
4,033
Shares Held
737M
Call Options Held
8.26M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $746B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email